Tag: share

VANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Hypercharge Networks Corp. (TSXV: HC; OTC: HCNWF; FSE: PB7) (the “Company” or “Hypercharge”), a leading EV charging operator, is announcing it has granted 2,630,000 stock options (“Options”) to directors, officers, employees and consultants. Each Option is exercisable to purchase one common share in capital of the Company (a “Common Share”) at an exercise price of $0.08, for a 5-year term. 2,530,000 Options are to vest as to 25% every six months for two years and 100,000 Options will vest 100% at issuance.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

Not for distribution to U.S. Newswire services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

Guangdong, China, June 16, 2026 (GLOBE NEWSWIRE) -- Wing Yip Food Holdings Group Limited (the “Company” or “Wing Yip”) (Nasdaq: WYHG), a meat product processing company in mainland China, today announced that it received a formal notification from the Nasdaq Stock Market LLC (“Nasdaq”) on June 16, 2026 that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the Company’s American Depositary Shares (“ADSs”) to maintain a minimum bid price of US$1.00 per share. As previously disclosed, on December 22, 2025, the Company received a notification from Nasdaq indicating that the closing bid price of the Company’s ADSs had been below US$1.00 per share for the prior 30 consecutive business days and that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2).

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”), of the important August 4, 2026 lead plaintiff deadline.

NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Roblox Corporation (NYSE: RBLX) between October 30, 2025 and April 30, 2026, inclusive (the “Class Period”), of the important August 7, 2026 lead plaintiff deadline.

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global GLP-1 Receptor Agonist Market size & share revenue was valued at approximately USD 28.7 Billion in 2025 and is expected to reach USD 34.2 Billion in 2026 and is expected to reach around USD 95.3 Billion by 2035, at a CAGR of 12.1% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Pfizer Inc., Merck & Co. Inc., Zealand Pharma A/S, Hanmi Pharmaceutical Co. Ltd. and others.